Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124380902 | 12438090 | 2 | F | 20160516 | 20160629 | 20160606 | 20160701 | EXP | CN-GLAXOSMITHKLINE-CN2016GSK071969 | GLAXOSMITHKLINE | 73.00 | YR | F | Y | 65.00000 | KG | 20160701 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124380902 | 12438090 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), QD | 21077 | 1 | DF | INHALATION POWDER | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124380902 | 12438090 | 1 | Dyspnoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124380902 | 12438090 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124380902 | 12438090 | Asthma | |
| 124380902 | 12438090 | Drug dose omission | |
| 124380902 | 12438090 | Drug ineffective | |
| 124380902 | 12438090 | Drug ineffective for unapproved indication | |
| 124380902 | 12438090 | Dyspnoea | |
| 124380902 | 12438090 | Product quality issue | |
| 124380902 | 12438090 | Suspected counterfeit product |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124380902 | 12438090 | 1 | 20160516 | 0 |